# clm_8CEE5F0631D9

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 9,485,000,000 United States dollar  
valid_from: 2020-03-31  
valid_to: 2020-06-30  
published: 2020-05-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A29CDA8096D2  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 9,485,000,000 United States dollar", as of 2020-03-31 (until 2020-06-30). Claim clm_8CEE5F0631D9, https://asof.is/claim/clm_8CEE5F0631D9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815420000031/0000318154-20-000031-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2020, filed 2020-05-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815420000031/0000318154-20-000031-index.htm (primary, SEC EDGAR 10-Q Q1 FY2020, published 2020-05-01)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 9,673,000,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_8CEE5F0631D9](/claim/clm_8CEE5F0631D9.md) | [clm_183536BBBD61](/claim/clm_183536BBBD61.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
